This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Imaging in Sarcoma
- 18F-FDG PET SUVmax Correlates with Osteosarcoma Histologic Response to Neoadjuvant Chemotherapy: Preclinical Evaluation in an Orthotopic Rat Model
- NCCN Task Force: Clinical Utility of PET in a Variety of Tumor Types
- 11C-Methionine vs. 18F-FDG PET in Soft Tissue Sarcoma Patients Treated with Neoadjuvant Therapy: Preliminary Results
- PET for Sarcomas Other Than Gastrointestinal Stromal Tumors
- Detection and Grading of Soft Tissue Sarcomas of the Extremities with 18F-3'-Fluoro-3'-Deoxy-L-Thymidine
- Shortened PET Data Acquisition Protocol for the Quantification of 18F-FDG Kinetics
- PET Imaging of Osteosarcoma
- Soft Tissue Sarcomas of Adults: State of the Translational Science
- 18F-FDG PET for the Diagnosis and Grading of Soft-Tissue Sarcoma: A Meta-Analysis
- A Tabulated Summary of the FDG PET Literature
- Is There a Role for FDG PET in the Diagnosis of Musculoskeletal Neoplasms?
- Grading of Tumors and Tumorlike Lesions of Bone: Evaluation by FDG PET
- Imaging of Soft-Tissue Tumors Using L-3-[Iodine-123]Iodo-{{alpha}}-methyl-tyrosine Single Photon Emission Computed Tomography: Comparison with Proliferative and Mitotic Activity, Cellularity, and Vascularity
- (F-18) Fluorodeoxyglucose Positron Emission Tomography as a Predictor of Pathologic Grade and Other Prognostic Variables in Bone and Soft Tissue Sarcoma
- Evaluation of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1
- Current role of positron emission tomography in thoracic oncology